Marianne Nugent Named Global Head of Illingworth Research Group
Illingworth Research Group™ (Illingworth), a leading provider of clinical research home health services, has announced the appointment of Marianne Nugent as the Company’s Global Head. In her new role, Nugent will oversee the expansion of Illingworth mobile research capabilities to support clinical trials focusing on the best interest of patients. Illingworth is part of Syneos Health®, the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success.
Previously, Nugent was Managing Director for Syneos Health, overseeing its Full-Service Commercial offer. In this role, she successfully navigated across the Syneos Health network, integrating cross-functional teams to bring forward dynamic solutions and holistic views on client assets. Nugent brings a wealth of experience to her new appointment, having worked in the biopharmaceutical and commercial solutions industries for more than 25 years. She has held positions in business development, recruiting, marketing, training and development, operations and sales, all providing her with deep experience across all facets of customer engagement and industry partnerships.
“More than ever, we recognize the importance of prioritizing human relationships at every healthcare encounter and strengthening insights to speed the delivery of life-changing therapies to patients. The patient-focused solutions, including mobile research nursing, and the PatientGo and SourceGo technology-enabled platforms provided by Illingworth, have never been more relevant,” said Maria Fotiu, Executive Vice President, Site and Patient Solutions, Syneos Health. “We’re excited to welcome Marianne to this role and look forward to how she elevates the awareness and expansion of these solutions to enhance what Syneos Health provides across the product lifecycle continuum to solve client challenges.”
As an expert in strategic planning and operations, Nugent is adept in establishing key relationships and networking. Previous roles include ten years on the manufacturer’s side of the industry with Bristol-Myers Squibb and Organon, Inc. (now Merck), and in the outsourcing space serving on the executive teams of two Contract Sales Organizations. She also has experience as an independent consultant, providing commercialization planning for emerging medical and marketing communication companies.
About Illingworth Research Group
Illingworth Research Group™, a Syneos Health® company, is a leading provider of clinical research home health services, providing highly trained, qualified and experienced research nurses to the biopharmaceutical and medical device industries. Building on our long-standing home health experience, we also provide complimentary patient-focused CRO services. Illingworth Research Group – awarded the 2020 SCRIP Best Specialist Provider Award and the 2021 Queens Award for Enterprise – operates in more than 46 countries, delivering the highest standards of clinical care and regulatory adherence across a diverse range of therapeutic areas. To learn more about our unique approach to clinical trial delivery visit illingworthresearch.com.